UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell disease.
Canada’s Solve FSHD provides $1.4m for rare muscle dystrophy therapy – Pharmaceutical Technology
FSHD is a rare genetic disease that results in progressive muscle degeneration, atrophy, and weakness of selected muscles in the body. Image Credit: Allexxandar /